Oragenics unveils automated intranasal device for treating concussed patients (NYSE:OGEN)
2024-06-27
Oragenics (NYSE:OGEN) on Thursday said that it had completed the development of its prototype of its automated intranasal device that would help in treating concussed patients. The company added that a phase II study is being designed to analyze the effectiveness of ONP-002 on blood biomarkers and patient-reported outcomes ofContinue Reading